Jiao Chang

607 total citations
28 papers, 432 citations indexed

About

Jiao Chang is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Jiao Chang has authored 28 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Jiao Chang's work include Nanoplatforms for cancer theranostics (6 papers), RNA modifications and cancer (5 papers) and Epigenetics and DNA Methylation (4 papers). Jiao Chang is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), RNA modifications and cancer (5 papers) and Epigenetics and DNA Methylation (4 papers). Jiao Chang collaborates with scholars based in China, New Zealand and Czechia. Jiao Chang's co-authors include Yi‐Chao Zheng, Yongyong Li, Weimin Yin, Yahui Liu, Yuge Zhao, Meng Zhao, Haiqing Dong, Hong‐Min Liu, Li Song and Zhuoyu Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Advanced Functional Materials.

In The Last Decade

Jiao Chang

27 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiao Chang China 13 245 126 93 76 73 28 432
Sung-Won Shin South Korea 14 310 1.3× 103 0.8× 111 1.2× 64 0.8× 44 0.6× 24 553
Jiafeng Gao China 15 250 1.0× 101 0.8× 79 0.8× 62 0.8× 70 1.0× 22 472
Igor Piotrowski Poland 13 191 0.8× 102 0.8× 176 1.9× 76 1.0× 70 1.0× 31 545
Fang Sui China 14 394 1.6× 142 1.1× 137 1.5× 56 0.7× 68 0.9× 33 663
Chao Feng China 12 252 1.0× 96 0.8× 90 1.0× 53 0.7× 39 0.5× 27 413
Xiaohan Lou China 11 186 0.8× 69 0.5× 75 0.8× 40 0.5× 80 1.1× 21 386
Haijun Lu China 11 216 0.9× 126 1.0× 92 1.0× 57 0.8× 44 0.6× 30 410
Hamidreza Saebfar Iran 9 265 1.1× 154 1.2× 106 1.1× 61 0.8× 36 0.5× 10 421
Qiuyi Choo Singapore 9 221 0.9× 56 0.4× 129 1.4× 56 0.7× 67 0.9× 10 442
K.G.K. Deepak India 4 251 1.0× 115 0.9× 187 2.0× 83 1.1× 109 1.5× 4 481

Countries citing papers authored by Jiao Chang

Since Specialization
Citations

This map shows the geographic impact of Jiao Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiao Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiao Chang more than expected).

Fields of papers citing papers by Jiao Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiao Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiao Chang. The network helps show where Jiao Chang may publish in the future.

Co-authorship network of co-authors of Jiao Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiao Chang. A scholar is included among the top collaborators of Jiao Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiao Chang. Jiao Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yan, Haibo Yang, Jiao Chang, et al.. (2025). Nanotechnology applications in the regulation of metabolic diseases. Coordination Chemistry Reviews. 538. 216736–216736. 1 indexed citations
2.
Luo, Ying, Le Kuai, Ying Zhang, et al.. (2025). An approach for psoriasis of microneedle patch simultaneously targeting multiple inflammatory cytokines and relapse related T cells. Biomaterials. 318. 123120–123120. 6 indexed citations
3.
Yin, Weimin, Jiao Chang, Hui Zhi, et al.. (2025). Copper deposited metal-phenolic networks enabled crosstalk between cuproptosis and ferroptosis for triple-negative breast cancer immunotherapy. Chemical Engineering Journal. 515. 163577–163577. 5 indexed citations
4.
Chang, Jiao, Weimin Yin, Hui Zhi, et al.. (2024). Copper Deposition in Polydopamine Nanostructure to Promote Cuproptosis by Catalytically Inhibiting Copper Exporters of Tumor Cells for Cancer Immunotherapy. Small. 20(27). e2308565–e2308565. 41 indexed citations
5.
Gu, Jingjing, Jiao Chang, Shiyu Chen, et al.. (2024). Suppressing the Hypoxia‐Adenosinergic Axis by a Tailored Nanoreactor for Enhanced Photothermal Immunotherapy. SHILAP Revista de lepidopterología. 4(4). 2300242–2300242. 3 indexed citations
6.
Zhao, Yuge, Weimin Yin, Zichen Yang, et al.. (2024). Nanotechnology-enabled M2 macrophage polarization and ferroptosis inhibition for targeted inflammatory bowel disease treatment. Journal of Controlled Release. 367. 339–353. 30 indexed citations
7.
Chang, Jiao, et al.. (2023). Multi-component immune knockout: A strategy for studying the effective components of traditional Chinese medicine. Journal of Chromatography A. 1692. 463853–463853. 6 indexed citations
8.
9.
Zhao, Meng, Chen Huang, Boyu Pan, et al.. (2023). SYVN1-mediated ubiquitylation directs localization of MCT4 in the plasma membrane to promote the progression of lung adenocarcinoma. Cell Death and Disease. 14(10). 666–666. 8 indexed citations
10.
Yin, Weimin, Jiao Chang, Yuge Zhao, et al.. (2023). Arginine nanoparticles mediated closed-loop ferroptosis enhancement for T cell activity boosting in cancer immunotherapy. Applied Materials Today. 36. 102047–102047. 4 indexed citations
11.
Ruan, Shuangrong, Weimin Yin, Jiao Chang, et al.. (2022). Acidic and hypoxic tumor microenvironment regulation by CaO2-loaded polydopamine nanoparticles. Journal of Nanobiotechnology. 20(1). 544–544. 30 indexed citations
12.
Wang, Yuchuan, Pengcheng Liu, Jiao Chang, Yunping Xu, & Jiangyun Wang. (2021). Site‐Specific Selenocysteine Incorporation into Proteins by Genetic Engineering. ChemBioChem. 22(20). 2918–2924. 9 indexed citations
13.
Zhao, Meng, Jiao Chang, Ran Liu, et al.. (2020). miR‐495 and miR‐5688 are down‐regulated in non‐small cell lung cancer under hypoxia to maintain interleukin‐11 expression. Cancer Communications. 40(9). 435–452. 17 indexed citations
14.
Zhao, Meng, et al.. (2020). Serum amyloid a, a potential biomarker both in serum and tissue, correlates with ovarian cancer progression. Journal of Ovarian Research. 13(1). 67–67. 21 indexed citations
15.
Zhao, Meng, Yahui Liu, Jiao Chang, et al.. (2019). ILF2 cooperates with E2F1 to maintain mitochondrial homeostasis and promote small cell lung cancer progression. Cancer Biology and Medicine. 16(4). 771–783. 20 indexed citations
16.
Zhao, Meng, et al.. (2018). Upregulation of IL-11, an IL-6 Family Cytokine, Promotes Tumor Progression and Correlates with Poor Prognosis in Non-Small Cell Lung Cancer. Cellular Physiology and Biochemistry. 45(6). 2213–2224. 53 indexed citations
17.
Zheng, Yi‐Chao, et al.. (2018). Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target. European Journal of Medicinal Chemistry. 161. 131–140. 40 indexed citations
18.
Shen, Dandan, et al.. (2018). Development of formaldehyde dehydrogenase-coupled assay and antibody-based assays for ALKBH5 activity evaluation. Journal of Pharmaceutical and Biomedical Analysis. 162. 9–15. 12 indexed citations
19.
Zhao, Li‐Juan, Ting Zhang, Xuejian Feng, et al.. (2018). USP28 contributes to the proliferation and metastasis of gastric cancer. Journal of Cellular Biochemistry. 120(5). 7657–7666. 25 indexed citations
20.
Zheng, Yi‐Chao, Jiao Chang, Ting Zhang, et al.. (2017). An Overview on Screening Methods for Lysine Specific Demethylase 1 (LSD1) Inhibitors. Current Medicinal Chemistry. 24(23). 2496–2504. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026